Golden
Petal

Petal

Petal is a New York City-based company founded in 2016 by Jack Arenas, Andrew Endicott, Jason Gross and David Ehrich.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

January 2019

Petal raises a $30,000,000 series B round from Valar Ventures, Third Prime Capital, Rosecliff Ventures, Greyhound Capital, Story Ventures, RiverPark Ventures and Afore Capital.

January 2018

Petal raises a $13,000,000 series A round from Valar Ventures.

September 2017

Petal raises a $3,600,000 seed round from Great Oaks Venture Capital, Brooklyn Bridge Ventures, Rosecliff Ventures, Story Ventures, Guild Capital and Afore Capital.

People

Name
Role
LinkedIn

Andrew Endicott

Founder



Ariana Poursartip

Employee



Cameron Spiller

Employee



carl bartsch

Employee



Chris Cunningham

Investor



David Ehrich

Founder



David T. Han

Employee



Dylan Field

Investor



Everett Knag

Employee



Gaurav Jain

Investor



Greg Arrese

Investor



Henry McNamara

Investor



Jack Arenas

Founder



Jake Yormak

Investor



Jason Gross

Founder



Keith Hamlin

Investor



Kevin Weatherman

Investor



Liza Gordon

Employee



Mark Egerman

Advisor



Namek T. Zu'bi

Investor



Nathan Kane

Employee



Nik Milanović

Employee



Rockman Ha

Employee



Shyam Kodangattil

Employee



Sue Choe

Employee



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









News

Title
Author
Date
Publisher
Description
December 12, 2019
WebWire
A major study conducted by the National Heart, Lung and Blood Institute's Prevention and Early Treatment of Acute Lung Injury (PETAL) Network into whether high doses of vitamin D can improve health outcomes for critically ill patients has concluded that such supplements do not reduce mortality or improve other non-fatal outcomes. The results of the Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET) study, which included contributions from over 200 researchers at 44 acade...